Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-30 · accession 0001415889-25-015480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-03 | 2025-05-30 | TSHA | Manning Paul B | 10% | P - Purchase | $2.75 | +750.0K | 2.84M | +36% | +$2.06M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | P | A | 750,000 | $2.75 | 2,841,704 | I See footnote | — | — | (F1) The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. |